
Hikma Pharmaceuticals PLC
Pharmaceuticals
Company Summary
Hikma Pharmaceuticals PLC is a pharmaceutical company that develops, manufactures, and sells a variety of generic, branded, and in-licensed pharmaceuticals. Solid, semi-solid, liquid, and injectable final dosage forms are available from the company. Injectables, Generics, and Branded are the three segments through which it works. The company was created in 1978 and is headquartered in London, England.
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
29.5
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
Refinitiv
Overall ESG Rating :
71
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
MSCI
Overall ESG Rating :
BBB
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader
Hikma is average among 80 companies in the pharmaceuticals industry.
Temperature Rise :
1.7℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned